Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...
No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...
The National Health Laboratory (LNS) has confirmed that it has managed to cut waiting times for biopsy results by more than half within the space of a year.